These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25008357)

  • 21. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers.
    Verdonschot JAJ; Robinson EL; James KN; Mohamed MW; Claes GRF; Casas K; Vanhoutte EK; Hazebroek MR; Kringlen G; Pasierb MM; van den Wijngaard A; Glatz JFC; Heymans SRB; Krapels IPC; Nahas S; Brunner HG; Szklarczyk R
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1049. PubMed ID: 31880413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency.
    Diofano F; Weinmann K; Schneider I; Thiessen KD; Rottbauer W; Just S
    PLoS Genet; 2020 Nov; 16(11):e1009088. PubMed ID: 33137814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated Autophagy and Sarcomere Dysfunction in Patients With Heart Failure With Co-Occurrence of P63A and P380S
    Martin TG; Pak H; Gerhard GS; Merali S; Merali C; Lemster B; Dubey P; McTiernan CF; Bristow MR; Feldman AM; Kirk JA
    J Am Heart Assoc; 2023 Dec; 12(24):e029938. PubMed ID: 38108245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.
    Jansweijer JA; Nieuwhof K; Russo F; Hoorntje ET; Jongbloed JD; Lekanne Deprez RH; Postma AV; Bronk M; van Rijsingen IA; de Haij S; Biagini E; van Haelst PL; van Wijngaarden J; van den Berg MP; Wilde AA; Mannens MM; de Boer RA; van Spaendonck-Zwarts KY; van Tintelen JP; Pinto YM
    Eur J Heart Fail; 2017 Apr; 19(4):512-521. PubMed ID: 27813223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of a dilated cardiomyopathy-associated variant in BAG3 using genome-edited iPSC-derived cardiomyocytes.
    McDermott-Roe C; Lv W; Maximova T; Wada S; Bukowy J; Marquez M; Lai S; Shehu A; Benjamin I; Geurts A; Musunuru K
    JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAG3 Pro209 mutants associated with myopathy and neuropathy relocate chaperones of the CASA-complex to aggresomes.
    Adriaenssens E; Tedesco B; Mediani L; Asselbergh B; Crippa V; Antoniani F; Carra S; Poletti A; Timmerman V
    Sci Rep; 2020 May; 10(1):8755. PubMed ID: 32472079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy.
    Mazzarotto F; Tayal U; Buchan RJ; Midwinter W; Wilk A; Whiffin N; Govind R; Mazaika E; de Marvao A; Dawes TJW; Felkin LE; Ahmad M; Theotokis PI; Edwards E; Ing AY; Thomson KL; Chan LLH; Sim D; Baksi AJ; Pantazis A; Roberts AM; Watkins H; Funke B; O'Regan DP; Olivotto I; Barton PJR; Prasad SK; Cook SA; Ware JS; Walsh R
    Circulation; 2020 Feb; 141(5):387-398. PubMed ID: 31983221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-Phenotype Correlation in Familial
    Mėlinytė-Ankudavičė K; Šukys M; Plisienė J; Jurkevičius R; Ereminienė E
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.
    Kayvanpour E; Sedaghat-Hamedani F; Amr A; Lai A; Haas J; Holzer DB; Frese KS; Keller A; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2017 Feb; 106(2):127-139. PubMed ID: 27576561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
    Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
    Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss-of-function mutations in co-chaperone BAG3 destabilize small HSPs and cause cardiomyopathy.
    Fang X; Bogomolovas J; Wu T; Zhang W; Liu C; Veevers J; Stroud MJ; Zhang Z; Ma X; Mu Y; Lao DH; Dalton ND; Gu Y; Wang C; Wang M; Liang Y; Lange S; Ouyang K; Peterson KL; Evans SM; Chen J
    J Clin Invest; 2017 Aug; 127(8):3189-3200. PubMed ID: 28737513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.
    Millat G; Bouvagnet P; Chevalier P; Sebbag L; Dulac A; Dauphin C; Jouk PS; Delrue MA; Thambo JB; Le Metayer P; Seronde MF; Faivre L; Eicher JC; Rousson R
    Eur J Med Genet; 2011; 54(6):e570-5. PubMed ID: 21846512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of BAG3 in dilated cardiomyopathy and its association with Charcot-Marie-Tooth disease type 2.
    Yerabandi N; Kouznetsova VL; Kesari S; Tsigelny IF
    Acta Myol; 2022 Jun; 41(2):59-75. PubMed ID: 35832504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies.
    Qu HQ; Feldman AM; Hakonarson H
    J Am Heart Assoc; 2022 Dec; 11(23):e027373. PubMed ID: 36382946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.
    Waldmüller S; Erdmann J; Binner P; Gelbrich G; Pankuweit S; Geier C; Timmermann B; Haremza J; Perrot A; Scheer S; Wachter R; Schulze-Waltrup N; Dermintzoglou A; Schönberger J; Zeh W; Jurmann B; Brodherr T; Börgel J; Farr M; Milting H; Blankenfeldt W; Reinhardt R; Özcelik C; Osterziel KJ; Loeffler M; Maisch B; Regitz-Zagrosek V; Schunkert H; Scheffold T;
    Eur J Heart Fail; 2011 Nov; 13(11):1185-92. PubMed ID: 21750094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haploinsufficiency of mechanistic target of rapamycin ameliorates
    Ding Y; Dvornikov AV; Ma X; Zhang H; Wang Y; Lowerison M; Packard RR; Wang L; Chen J; Zhang Y; Hsiai T; Lin X; Xu X
    Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31492659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3.
    de Fuenmayor-Fernández de la Hoz CP; Lupo V; Bermejo-Guerrero L; Martín-Jiménez P; Hernández-Laín A; Olivé M; Gallardo E; Esteban-Pérez J; Espinós C; Domínguez-González C
    J Neurol; 2024 Feb; 271(2):986-994. PubMed ID: 37907725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.